In bladder cancer, p53 gene mutations are generally believed to indicate invasive bladder cancer and disease progression and to be useful as chemotherapy response markers, although some studies have come to contradictory conclusions (Schmitz-Drager et al. 2000; Sarkis et al. 1995; Sengelov et al. 1997). Here, TP53 is linked to urinary bladder carcinoma.